Last update March 21, 2022
Very Low Risk
We do not have alternatives for Drospirenone since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Drospirenone in other languages or writings:
Drospirenone belongs to this group or family:
Main tradenames from several countries containing Drospirenone in its composition:
|Tmax||3 - 4||hours|
|Theoretical Dose||0.0005 (0.0002 -0.001)||mg/Kg/d|
|Relative Dose||1.1 (0.4 - 2.1)||%|
Write us at email@example.com
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
It is a progestogen analog of spironolactone with antiandrogenic activity. Used as a contraceptive. Oral administration.
It is excreted in breast milk in a clinically insignificant amount and no problems have been reported in infants whose mothers took it. (Melka 2020, Blode 2001)
The manufacturing laboratory considers it compatible with breastfeeding. (AEMPS 2019, FDA 2019)
During breastfeeding progestin-only contraceptives are preferable to those combined with estrogen and, in this case, those with a lower dose of estrogen. (CDC 2016, 2013 y 2010, WHO/OMS 2015, Altshuler 2015, Berens 2015, CLM 2012, Moretti 2000)
For the first 4-6 weeks postpartum, non-hormonal methods are the first choice, followed by IUDs and progestogen implants. (Berens 2015, Mwalwanda 2013, Rowe 2013, CLM 2012)
See below the information of this related product: